BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7121529)

  • 41. The management of severe recurrent epistaxis due to hereditary hemorrhagic telangiectasia using regional facial cutaneous flaps.
    Strauss M; Zohar Y; Laurian N
    J Laryngol Otol; 1985 Apr; 99(4):373-7. PubMed ID: 4009036
    [No Abstract]   [Full Text] [Related]  

  • 42. Neodymium-YAG laser intranasal photocoagulation in hereditary hemorrhagic telangiectasia: an update report.
    Kluger PB; Shapshay SM; Hybels RL; Bohigian RK
    Laryngoscope; 1987 Dec; 97(12):1397-401. PubMed ID: 3683050
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Management of epistaxis.
    Kucik CJ; Clenney T
    Am Fam Physician; 2005 Jan; 71(2):305-11. PubMed ID: 15686301
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [How to examine and pack a patient with epistaxis?].
    Dufour X
    Ann Otolaryngol Chir Cervicofac; 2007 Sep; 124(4):210-1. PubMed ID: 17692811
    [No Abstract]   [Full Text] [Related]  

  • 45. Management of epistaxis.
    Templer JW; Davis WE; Joseph DJ
    Mo Med; 1977 May; 74(5):210-2, 212A, 212D. PubMed ID: 865460
    [No Abstract]   [Full Text] [Related]  

  • 46. [Treatment of epistaxis in Rendu-Osler disease by intramucosal injection of ethibloc].
    Borsik M; Herbreteau D; Deffrennes D; Guichard JP; Aymard A; Merland JJ; Tran Ba Huy P
    Ann Otolaryngol Chir Cervicofac; 1992; 109(5):273-6. PubMed ID: 1292384
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Maxillary artery embolisation as a method of treatment of hemorrhages in Rendu-Osler-Weber Syndrome--our experience].
    Barnaś S; Wilczyński K; Kiszka M; Gerber-Sekula A; Nowicki J
    Otolaryngol Pol; 2007; 61(5):884-6. PubMed ID: 18552041
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The natural history of epistaxis in hereditary hemorrhagic telangiectasia.
    AAssar OS; Friedman CM; White RI
    Laryngoscope; 1991 Sep; 101(9):977-80. PubMed ID: 1886446
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A novel approach to manage recurrent epistaxis in outpatients with hereditary hemorrhagic telangiectasia.
    Cantone E; Marino A; Castagna G; Sicignano S; Rega F; Di Rubbo V; Iengo M
    Am J Emerg Med; 2014 Aug; 32(8):952.e1-2. PubMed ID: 24637140
    [No Abstract]   [Full Text] [Related]  

  • 50. A natural obturator in hereditary haemorrhagic telangiectasia.
    Soni-Jaiswal A; Woolford TJ
    J Laryngol Otol; 2009 Jun; 123(6):695-6. PubMed ID: 19275781
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recent trends in epistaxis management in the United States: 2008-2010.
    Villwock JA; Jones K
    JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1279-84. PubMed ID: 24136624
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Avastin and diode laser: a combined modality in managing epistaxis in hereditary hemorrhagic telangiectasia.
    Marglani OA; Bawazeer NA; Abu Suliman OA
    Am J Otolaryngol; 2013; 34(5):603-5. PubMed ID: 23541684
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Internal carotid artery epistaxis.
    Kleid MS; Millar HS
    Otolaryngol Head Neck Surg; 1986 Apr; 94(4):480-6. PubMed ID: 3086811
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical practice. Epistaxis.
    Schlosser RJ
    N Engl J Med; 2009 Feb; 360(8):784-9. PubMed ID: 19228621
    [No Abstract]   [Full Text] [Related]  

  • 55. Nosebleed in children. Background and techniques to stop the flow.
    McDonald TJ
    Postgrad Med; 1987 Jan; 81(1):217-24. PubMed ID: 3027678
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A modified technique for septodermoplasty in hereditary hemorrhagic telangiectasia.
    Rimmer J; Lund VJ
    Laryngoscope; 2014 Jan; 124(1):67-9. PubMed ID: 23832829
    [No Abstract]   [Full Text] [Related]  

  • 57. Endovascular treatment of epistaxis: indications, management, and outcome.
    Strach K; Schröck A; Wilhelm K; Greschus S; Tschampa H; Möhlenbruch M; Naehle CP; Jakob M; Gerstner AO; Bootz F; Schild HH; Urbach H
    Cardiovasc Intervent Radiol; 2011 Dec; 34(6):1190-8. PubMed ID: 21472510
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recurrent epistaxis in an adolescent male.
    McLaren O; Ronan N
    BMJ; 2019 Oct; 367():l5393. PubMed ID: 31582366
    [No Abstract]   [Full Text] [Related]  

  • 59. Selective endovascular embolization for refractory idiopathic epistaxis is a safe and effective therapeutic option: technique, complications, and outcomes.
    Cohen JE; Moscovici S; Gomori JM; Eliashar R; Weinberger J; Itshayek E
    J Clin Neurosci; 2012 May; 19(5):687-90. PubMed ID: 22364712
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Rendu-Osler disease. Follow-up of 6 patients treated by embolization. Nasal telecobaltotherapy in a refractory case].
    Esparcia Navarro M; Ferrer Baixauli F; Moya Albiol S; Vento Torres D; García Callejo FJ; Soler Marquessins F; Marco Algarra J
    Acta Otorrinolaringol Esp; 1999 Apr; 50(3):197-201. PubMed ID: 10362862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.